Single-Molecule Real-Time Sequencing (SMRT) Market Report 2026

Single-Molecule Real-Time Sequencing (SMRT) Market Overview

• Single-Molecule Real-Time Sequencing (SMRT) market size has reached to $3.36 billion in 2025 • Expected to grow to $4.9 billion in 2030 at a compound annual growth rate (CAGR) of 7.8% • Growth Driver: Rising Demand For Precision Medicine Fuels Growth In Single-Molecule Real-Time Sequencing (SMRT) Market • North America was the largest region in 2025.

What Is Covered Under Single-Molecule Real-Time Sequencing (SMRT) Market?

Single-molecule real-time (SMRT) sequencing is an advanced DNA sequencing technology that allows for the direct observation of DNA synthesis by monitoring fluorescently labeled nucleotides in real-time, enabling the production of long, continuous reads. This technology is beneficial for sequencing complex genomic regions and resolving structural variations. The main product types of single-molecule real-time sequencing (SMRT) are consumables, instruments, and services. Single-molecule real-time (SMRT) sequencing consumables are materials used in SMRT sequencing technologies, which are designed to sequence DNA or RNA molecules in real-time. These are used in various applications such as DNA sequencing, RNA sequencing, epigenetics, and whole genome sequencing, and also by various end-users such as hospitals, diagnostic laboratories, biopharmaceutical companies, academic institutes, and research centers, among others.

What Is The Single-Molecule Real-Time Sequencing (SMRT) Market Growth Forecast?

The single-molecule real-time sequencing (smrt) market size is expected to see strong growth in the next few years. It will grow to $4.9 billion in 2030 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to increasing use of precision medicine approaches, rising demand for population-scale genomics, expansion of clinical genomics applications, growing integration of ai-driven bioinformatics, increasing funding for advanced sequencing technologies. Major trends in the forecast period include increasing adoption of long-read sequencing technologies, rising use of smrt sequencing for structural variant detection, growing demand for high-accuracy epigenetic analysis, expansion of real-time sequencing workflows, enhanced focus on complex genome resolution.

Global Single-Molecule Real-Time Sequencing (SMRT) Market Segmentation

1) By Product: Consumable, Instrument, Services 2) By Application: DNA Sequencing, RNA Sequencing, Epigenetics, Whole Genome Sequencing, Other Applications 3) By End-Users: Hospitals, Diagnostic Laboratories, Biopharmaceutical Companies, Academic Institutes And Research Centers, Other End-Users Subsegments: 1) By Consumable: Reagents, Sample Preparation Kits, Flow Cells 2) By Instrument: SMRT Sequencers, Accessories, Software 3) By Services: Data Analysis Services, Sequencing Services, Technical Support Services

What Are The Drivers Of The Single-Molecule Real-Time Sequencing (SMRT) Market?

The rising demand for precision medicine is expected to propel the growth of the single-molecule real-time sequencing (SMRT) market going forward. Precision medicine, or personalized medicine, is a medical approach that tailors treatment and healthcare strategies to individual patients based on their genetic, environmental, and lifestyle factors. The increasing demand for personalized medicine is driven by advancements in genomic technologies, enabling more precise and tailored treatments and a growing emphasis on individualized patient care for better outcomes. Single-molecule real-time sequencing (SMRT) significantly enhances precision medicine by providing detailed and accurate genomic and epigenetic information, leading to better diagnosis, personalized treatment, and improved patient outcomes. For instance, in May 2025, according to the Personalized Medicine Coalition (PMC), in 2023, a U.S.-based professional organization, the U.S. Food and Drug Administration (FDA) approved 18 new personalized medicines, about 38% of all newly approved therapeutic molecular entities. Therefore, the rising demand for precision medicine drives growth in the single-molecule real-time sequencing (SMRT) industry. The rising incidence of genetic disorders is expected to propel the growth of the single-molecule real-time sequencing (SMRT) market going forward. Genetic disorders are health conditions caused by abnormalities in an individual's DNA, which can be inherited or occur due to mutations, affecting physical development, metabolism, or overall health. The growing incidence of genetic disorders is primarily driven by increased awareness, advancements in diagnostic technologies, and factors such as environmental influences and parental age. Single-molecule real-time sequencing (SMRT) is used in genetic disorders to provide accurate, long-read DNA sequences, enabling the detection of complex mutations and structural variations that traditional methods may miss. For instance, in March 2024, according to the Gene People, a UK-based registered charity for people with genetic disorders, over 6,000 genetic conditions exist, with new ones discovered daily. In the UK, 1 in 25 children is affected, resulting in 30,000 new diagnoses annually and over 2.4 million individuals living with genetic conditions. Therefore, the rising incidence of genetic disorders drives growth in the single-molecule real-time sequencing (SMRT) industry.

Key Players In The Global Single-Molecule Real-Time Sequencing (SMRT) Market

Major companies operating in the single-molecule real-time sequencing (smrt) market are Thermo Fisher Scientific Inc., Illumina Inc., Qiagen N.V., BGI Group, 10x Genomics Inc., Ginkgo Bioworks Inc., Oxford Nanopore Technologies Limited, Genewiz Inc., Pacific Biosciences of California Inc., Macrogen Inc., Element Biosciences Inc., Asuragen Inc., BioNano Genomics Inc., Zymo Research Corporation, Dovetail Genomics LLC, SeqWell Inc., Paragon Genomics Inc., Nabsys Inc., Eurofins Scientific SE, Novogene Corporation

What Are Latest Mergers And Acquisitions In The Single-Molecule Real-Time Sequencing (SMRT) Market?

In February 2023, SeqLL, a US-based company that offers sequencing instruments and services, including single-molecule real-time (SMRT) sequencing, partnered with the US Federal Bureau of Investigation to enhance the accuracy and reliability of identifying biological evidence in criminal investigations. This partnership aims to develop a sequencing-based forensic technology to enhance the analysis of biological evidence in criminal investigations. It would also leverage SeqLL's advanced sequencing capabilities to improve the accuracy and efficiency of forensic DNA analysis. The US Federal Bureau of Investigation is a US-based government law-enforcement agency.

Regional Outlook

North America was the largest region in the single-molecule real-time sequencing (SMRT) market in 2025. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Single-Molecule Real-Time Sequencing (SMRT) Market?

The single-molecule real-time sequencing (SMRT) market consists of revenues earned by entities by service contracts, data analysis, charging for the service and maintenance plans. The market value includes the value of related goods sold by the service provider or included within the service offering. The single-molecule real-time sequencing (SMRT) market also includes sales of sequencing kits, reagents, and specialized chips. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Single-Molecule Real-Time Sequencing (SMRT) Market Report 2026?

The single-molecule real-time sequencing (smrt) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the single-molecule real-time sequencing (smrt) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.